Karyopharm Therapeutics Inc

NASDAQ:KPTI   3:59:58 PM EDT
4.92
-0.24 (-4.65%)
Other Pre-Announcement

Karyopharm Reports Q2 Loss Per Share Of $0.62

Published: 08/04/2022 12:01 GMT
Karyopharm Therapeutics Inc (KPTI) - Karyopharm Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress.
Q2 Loss per Share $0.62.
Sees FY Revenue $155 Million to $165 Million.
Q2 2022 Total Revenue of $39.7 Million, Up 76% Versus Q2 2021.
Re-iterates Cash Runway to Early 2024.
Q2 Earnings per Share View $-0.63, Revenue View $35.6 Million -- Refinitiv Ibes Data (analyst estimates).